Atai stocks.

Sarah Popham. Linked companies : Atai Life Sciences N.V. Summary. Presently, Sarah Popham is Vice President-Regulatory Affairs for ATAI Life Sciences NV. She received an undergraduate degree from the University of Bradford. Current …Web

Atai stocks. Things To Know About Atai stocks.

377.43. -0.11%. 9.38M. View today's Atari stock price and latest ALATA news and analysis. Create real-time notifications to follow any changes in the live stock price.WebThe comedown has also put a dent in Angermayer’s wealth. Adjusting for its cash, investors now value Atai’s drug pipeline at $470 million. Nearly $1.8 billion was raised by psychedelics ...WebStock Symbol; ATAI; Investments; 19; Share Price; $1.09 (As of Wednesday Closing) ATAI Life Sciences General Information. Description. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

ATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWeb

ATAI Life Sciences N.V. analyst estimates, including ATAI earnings per share estimates and analyst recommendations.1.47M. 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...Mar 24, 2023 · atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditionsContinued ... 1.47M. 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...Find the latest Atari SA (PONGF) stock quote, history, news and other vital information to help you with your stock trading and investing.

ATAI's current price target is $12.80. Learn why top analysts are making this stock forecast for Atai Life Sciences at MarketBeat.

1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (ATAI 7.69%) stock. This 12-month price target implies an upside ...

1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (ATAI 7.69%) stock. This 12-month price target implies an upside ...NEW YORK and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health ...Find the latest Atari SA (ALATA.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.ATAI Life Sciences (NASDAQ: ATAI) is another clinical-stage biotech looking to make a mark in the mental health space. Its stock took a dive recently following failed results of its Phase 2a study ...The latest atai Life Sciences stock prices, stock quotes, news, and history to help you invest and trade smarter.Atai Life Sciences The Trade : Atai Life Sciences N.V. ATAI Florian Brand acquired a total of 20,000 shares at an average price of $1.16. The insider spent around $23,120 to buy those shares.Web

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Insider Trading.ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...How many ATAI shares are owned by institutional investors? 24.8M ATAI shares ... Trading stocks, options and other securities involves risk. The risk of loss ...The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...Stock Data; Quote. Stock Data. Quote · Charts · Historical Data. ATA Creativity ... ® Copyright 2023 atai.net.cn ATA Group All rights reserved 沪ICP备14030601号- ...Atai stock closed up 30% at 19.45 on the stock market today, paring gains after surging more than 50% earlier. Credit Suisse, Citigroup, Cowen, and Berenberg were book-running managers for the ...

ATAI Life Sciences Stock (NASDAQ: ATAI) stock price, news, charts, stock research, profile.According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ...

Oct 28, 2023 · 1. Atai Life Sciences. With prominent backing from venture capitalists, including billionaire Peter Thiel, it’s not surprising that Atai Life Sciences ranks as one of the biggest biotech stocks ... AI is a growth business. Total spending on AI systems is forecast to reach $97.9 billion in 2023, up from $37.5 billion in 2019. For the five-year period ending in 2023, the AI sector is predicted ...Aug 30, 2022 · ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ... Over the past 12 months, ATAI’s stock has witnessed a remarkable growth rate of 631.38%. Despite its impressive performance in the stock market, ATAI has faced its fair share of challenges since ...atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...Florian Brand's Atai Life Sciences went public three years after launching, fueled by Silicon Valley interest and promising science, but it's still waiting for its first big breakthrough.

The stock has given up three-quarters of its market value year to date. Ark Genomic bought 67,384 shares of Atai Life Sciences - Get Free Report, valued at $284,360. Atai is a Berlin ...

As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …

Atai Life Sciences’ (NASDAQ: ATAI) stock fell more than 40% after the primary endpoint of a phase 2a clinical trial examining the use of ketamine treatment to treat depression was not met.WebIn May 2021, Atai purchased additional preferred stock of Neuronasal. As of the date, the company now holds a 56.5% equity ownership position in Neuronasal – a company focused on treating concussions and other forms of …According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Contact Email [email protected]. Phone Number +49 (0) 89 2153 9035. ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that ...WebThe subreddit to share, discuss and enjoy the Stock journey of Atari SA. The creator of all time classics like Pong & Space Invaders on their way to celebrate 50 years of spreading joy! - A place to share news, stories and discuss everything related to the ATA and PONGF stock. Please keep in mind that Stock and Token posts can contain 100% ...The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...2 days ago · ATAI Life Sciences Stock (NASDAQ: ATAI) stock price, news, charts, stock research, profile. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $-0.42 · Market Cap. $185.93 M · Shares Outstanding. 166.01 M · Public Float. 114.08 M · Yield. ATAI is not ...ATAI Life Sciences NV ATAI Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing …Atai stock closed at $17.38 in Friday's trading session. Other coverage included an Outperform from Credit Suisse with a price target of $25; Buy ratings from Citigroup. HOME. MAIL.Web0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ...atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices in New York and London, our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.

According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,116.22%. The lowest target is $9.00 and the highest is $20. On average, analysts rate ATAI stock stock as a strong buy.Over the last 12 months, ATAI Life Sciences's shares have ranged in value from as little as $1.05 up to $3.65. A popular way to gauge a stock's volatility is its "beta". ATAI.US volatility (beta: 0.83) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is ...01/08/2023. ATARI: FY2023 ANNUAL RESULTS. Analytical report. Stock ATARI S.A. Common Stock FR0010478248 ALXP Euronext Growth Paris Live Euronext quotes, realtime prices, charts and regulated news.WebInstagram:https://instagram. arexvy vaccinebrokers that trade cryptocurrencyprivate health insurance new yorkdog insurance banfield Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis. can you make a living off of stocksnasdaq gfai On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. So far this year, Atai has tumbled more than 40% and Compass Pathways has fallen almost 60%. The Horizons Psychedelic Stock Index ETF, which tracks the North American Psychedelics Index , is down ... albirds stock On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10.